R43/R44 Small Business Innovation Research Grants (SBIR)
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas).
|Letter of Intent Due Date|
February 14, 2014
|Application Due Date|
March 14, 2014, by 5:00 PM local time of applicant organization.